BeyondSpring Inc.
BYSIAnalytical Summary
BeyondSpring Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.
19-Year Financial Trajectory
QuarterlyHealth Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2022 20-F ↗ | Q4 FY2022 Dec 31, 2021 20-F ↗ | Q4 FY2021 Dec 31, 2020 20-F ↗ | Q4 FY2020 Dec 31, 2019 20-F ↗ | Q4 FY2019 Dec 31, 2018 20-F ↗ | Q4 FY2018 Dec 31, 2017 20-F ↗ | Q4 FY2017 Dec 31, 2016 20-F ↗ | Q4 FY2016 Dec 31, 2015 20-F ↗ | Q4 FY2015 Dec 31, 2014 20-F ↗ | Q4 FY2014 Dec 31, 2013 20-F ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Growth YoY (%) | N/M |
-25.0%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
20.0%
Good
Good
Year-over-year change in earnings per share
Optimal:
> 10%
|
60.0%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income Growth YoY (%) | N/M |
-23.6%
Weak
↓
Weak
Declining
Year-over-year change in net income |
27.8%
Excellent
Excellent
Year-over-year change in net income |
55.2%
Excellent
Excellent
Year-over-year change in net income |
N/M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| FCF Growth YoY (%) |
24.4%
Good
↑
Good
Improving
Year-over-year change in free cash flow |
— |
21.9%
Good
↑
Good
Improving
Year-over-year change in free cash flow |
18.1%
Good
Good
Year-over-year change in free cash flow |
22.0%
Good
Good
Year-over-year change in free cash flow |
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2022 20-F ↗ | Q4 FY2022 Dec 31, 2021 20-F ↗ | Q4 FY2021 Dec 31, 2020 20-F ↗ | Q4 FY2020 Dec 31, 2019 20-F ↗ | Q4 FY2019 Dec 31, 2018 20-F ↗ | Q4 FY2018 Dec 31, 2017 20-F ↗ | Q4 FY2017 Dec 31, 2016 20-F ↗ | Q4 FY2016 Dec 31, 2015 20-F ↗ | Q4 FY2015 Dec 31, 2014 20-F ↗ | Q4 FY2014 Dec 31, 2013 20-F ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Effective Tax Rate (%) (%) |
-8.9%
Excellent
↓
Excellent
Declining
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
-0.9%
Excellent
↑
Excellent
Improving
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
-1.5%
Excellent
↑
Excellent
Improving
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
-1.2%
Excellent
↑
Excellent
Improving
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
-0.8%
Excellent
↑
Excellent
Improving
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
-5.3%
Excellent
↓
Excellent
Declining
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
0.0%
Excellent
→
Excellent
Stable
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
0.0%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
0.0%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— | — | — | — | — | — | — | — | — | — |
| FCF / Net Income (x) |
1.52x
Excellent
↓
Excellent
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
2.58x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
2.72x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
3.25x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.95x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.55x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
2.52x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.73x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.63x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — | — | — | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2022 20-F ↗ | Q4 FY2022 Dec 31, 2021 20-F ↗ | Q4 FY2021 Dec 31, 2020 20-F ↗ | Q4 FY2020 Dec 31, 2019 20-F ↗ | Q4 FY2019 Dec 31, 2018 20-F ↗ | Q4 FY2018 Dec 31, 2017 20-F ↗ | Q4 FY2017 Dec 31, 2016 20-F ↗ | Q4 FY2016 Dec 31, 2015 20-F ↗ | Q4 FY2015 Dec 31, 2014 20-F ↗ | Q4 FY2014 Dec 31, 2013 20-F ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Invested Capital (%) |
7.0%
Fair
→
Fair
Stable
Return earned on debt + equity capital invested
Optimal:
> 10%
|
8.1%
Fair
↑
Fair
Improving
Return earned on debt + equity capital invested
Optimal:
> 10%
|
5.7%
Caution
↓
Caution
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
6.5%
Caution
↓
Caution
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
9.3%
Fair
Fair
Return earned on debt + equity capital invested
Optimal:
> 10%
|
5.4%
Caution
Caution
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — | — | — | — | — | — | — | — | — | — | — | — |
| Return on Capital (%) (%) |
-12.1%
Weak
↓
Weak
Declining
Operating profit relative to total assets
Optimal:
> 10%
|
-10.0%
Weak
↓
Weak
Declining
Operating profit relative to total assets
Optimal:
> 10%
|
-6.1%
Weak
→
Weak
Stable
Operating profit relative to total assets
Optimal:
> 10%
|
-6.3%
Weak
→
Weak
Stable
Operating profit relative to total assets
Optimal:
> 10%
|
-7.0%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
-5.0%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — | — | — | — | — | — | — | — | — | — | — |
| Return on Common Equity (%) (%) |
6.3%
Caution
↑
Caution
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-58%)
|
6.6%
Caution
↑
Caution
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-56%)
|
4.8%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-68%)
|
6.0%
Caution
↑
Caution
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-60%)
|
-15.8%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-205%)
|
5.3%
Caution
Caution
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-65%)
|
— | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2022 20-F ↗ | Q4 FY2022 Dec 31, 2021 20-F ↗ | Q4 FY2021 Dec 31, 2020 20-F ↗ | Q4 FY2020 Dec 31, 2019 20-F ↗ | Q4 FY2019 Dec 31, 2018 20-F ↗ | Q4 FY2018 Dec 31, 2017 20-F ↗ | Q4 FY2017 Dec 31, 2016 20-F ↗ | Q4 FY2016 Dec 31, 2015 20-F ↗ | Q4 FY2015 Dec 31, 2014 20-F ↗ | Q4 FY2014 Dec 31, 2013 20-F ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt to Equity (x) | — | — | — | — | — | — | — | — | — | — |
0.00x
Excellent
↓
Excellent
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-100%)
|
0.02x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-96%)
|
0.05x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-92%)
|
— | — | — | — | — | — |
| Net Debt (USD) | $-4.04M | $-7.79M | $-12.48M | $-9.54M | $-6.53M | $-2.92M | — | — | — | $-34.40M | $-41.62M | $-107.37M | $-34.50M | $-3.89M | $-27.48M | $-11.69M | $-10.82M | $-392.00K | $-8.00K |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2022 20-F ↗ | Q4 FY2022 Dec 31, 2021 20-F ↗ | Q4 FY2021 Dec 31, 2020 20-F ↗ | Q4 FY2020 Dec 31, 2019 20-F ↗ | Q4 FY2019 Dec 31, 2018 20-F ↗ | Q4 FY2018 Dec 31, 2017 20-F ↗ | Q4 FY2017 Dec 31, 2016 20-F ↗ | Q4 FY2016 Dec 31, 2015 20-F ↗ | Q4 FY2015 Dec 31, 2014 20-F ↗ | Q4 FY2014 Dec 31, 2013 20-F ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Working Capital (USD) | $1.13M | $7.31M | $11.52M | $13.98M | $18.86M | $17.57M | — | — | — | $31.17M | $59.97M | $99.63M | $30.81M | $-10.57M | $27.55M | $12.10M | $9.62M | — | — |
| LT Debt (USD) | — | — | — | — | — | — | — | — | — | — | $0.00 | $2.17M | $1.44M | — | — | — | — | — | — |
| Total Equity (USD) | $-34.49M | $-32.16M | $-31.77M | $-30.22M | $-28.31M | $-32.90M | — | — | — | $-5.98M | $26.68M | $88.34M | $30.28M | $-7.77M | $27.08M | $12.15M | $8.95M | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2022 20-F ↗ | Q4 FY2022 Dec 31, 2021 20-F ↗ | Q4 FY2021 Dec 31, 2020 20-F ↗ | Q4 FY2020 Dec 31, 2019 20-F ↗ | Q4 FY2019 Dec 31, 2018 20-F ↗ | Q4 FY2018 Dec 31, 2017 20-F ↗ | Q4 FY2017 Dec 31, 2016 20-F ↗ | Q4 FY2016 Dec 31, 2015 20-F ↗ | Q4 FY2015 Dec 31, 2014 20-F ↗ | Q4 FY2014 Dec 31, 2013 20-F ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | $0.00 | — | $0.00 | $0.00 | $0.00 | — | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — | — | — |
| Depreciation Expense (USD) | $19.00K | $-156.00K | $81.00K | $82.00K | $80.00K | $20.00K | $83.00K | $115.00K | $67.00K | — | — | — | — | — | — | — | — | — | — |
| Net Income, GAAP (USD) | $-2.16M | $-2.14M | $-1.54M | $-1.81M | $4.48M | $-1.73M | $-2.13M | $-4.03M | $-3.23M | — | — | — | — | — | — | — | — | — | — |
| Operating Cash Flow (USD) | $-3.28M | $-5.50M | $-4.19M | $-5.87M | $-4.20M | $982.00K | $-5.17M | $-6.99M | $-5.27M | — | — | — | — | — | — | — | — | — | — |
Secondary lens
Benchmark Lens
Compare BYSI against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare BYSI against peers after checking the statement evidence.
Percentile Rankings
How BYSI compares to all companies
Peer Comparison
BYSI vs similar peers
Compare BYSI with peers
Stack BYSI against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 12 years · 19 quarters